Weight-Loss Injections: Large Study Shows Significant Health Benefits, Rare Risks
A study of nearly two million veterans with type-2 diabetes found that GLP-1 receptor agonists (like Ozempic and Wegovy) significantly reduced risks of heart disease, stroke, neurodegenerative diseases, and mental health issues, despite some rare but serious side effects like pancreatitis and kidney...
Weight-Loss Injections: Large Study Shows Significant Health Benefits, Rare Risks
A study of nearly two million veterans with type-2 diabetes found that GLP-1 receptor agonists (like Ozempic and Wegovy) significantly reduced risks of heart disease, stroke, neurodegenerative diseases, and mental health issues, despite some rare but serious side effects like pancreatitis and kidney...
Progress
40% Bias Score
Weight-Loss Injections Strain UK NHS
Two injectable weight-loss medications, Wegovy and Mounjaro, are showing efficacy in the UK, but concerns exist regarding increased demand on the NHS, limited availability, and private market costs ranging from £200-£300 per pen.
Weight-Loss Injections Strain UK NHS
Two injectable weight-loss medications, Wegovy and Mounjaro, are showing efficacy in the UK, but concerns exist regarding increased demand on the NHS, limited availability, and private market costs ranging from £200-£300 per pen.
Progress
20% Bias Score